Thomas P Miller

  • 18820 Citations
  • 57 h-Index
1978 …2021
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1979 2016

  • 18820 Citations
  • 57 h-Index
  • 164 Article
  • 2 Chapter
  • 1 Letter
Filter
Article
2004
165 Citations (Scopus)

Utility of fine-needle aspiration as a diagnostic technique in lymphoma

Hehn, S. T., Grogan, T. M. & Miller, T. P., 2004, In : Journal of Clinical Oncology. 22, 15, p. 3046-3052 7 p.

Research output: Contribution to journalArticle

Fine Needle Biopsy
Lymphoma
Biopsy
Immunophenotyping
Matched-Pair Analysis
10 Citations (Scopus)

What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?

Hehn, S. T. & Miller, T. P., Jan 2004, In : Current hematology reports. 3, 1, p. 17-26 10 p.

Research output: Contribution to journalArticle

Bleomycin
Hodgkin Disease
Doxorubicin
Vinblastine
Vincristine
2003
151 Citations (Scopus)

A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911

Press, O. W., Unger, J. M., Braziel, R. M., Maloney, D. G., Miller, T. P., LeBlanc, M., Gaynor, E. R., Rivkin, S. E. & Fisher, R. I., Sep 1 2003, In : Blood. 102, 5, p. 1606-1612 7 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Oncology
Chemotherapy
Iodine
Non-Hodgkin's Lymphoma
50 Citations (Scopus)

Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501

Velasquez, W. S., Lew, D., Grogan, T. M., Spiridonidis, C. H., Balcerzak, S. P., Dakhil, S. R., Miller, T. P., Lanier, K. S., Chapman, R. A. & Fisher, R. I., May 15 2003, In : Journal of Clinical Oncology. 21, 10, p. 1996-2003 8 p.

Research output: Contribution to journalArticle

Mitoxantrone
Non-Hodgkin's Lymphoma
Disease-Free Survival
Vincristine
Prednisone
9 Citations (Scopus)

Directed indices for exploring gene expression data

LeBlanc, M., Kooperberg, C., Grogan, T. M. & Miller, T. P., Apr 12 2003, In : Bioinformatics. 19, 6, p. 686-693 8 p.

Research output: Contribution to journalArticle

Gene Expression Data
Gene expression
Genes
Gene
Gene Expression
67 Citations (Scopus)

Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: A phase II study of the Southwest Oncology Group (SWOG 9349)

Blayney, D. W., LeBlanc, M. L., Grogan, T., Gaynor, E. R., Chapman, R. A., Spiridonidis, C. H., Taylor, S. A., Bearman, S. I., Miller, T. P. & Fisher, R. I., Jul 1 2003, In : Journal of Clinical Oncology. 21, 13, p. 2466-2473 8 p.

Research output: Contribution to journalArticle

Vincristine
Prednisone
Non-Hodgkin's Lymphoma
Doxorubicin
Cyclophosphamide
93 Citations (Scopus)

Gene expression profile of serial samples of transformed B-cell lymphomas

De Vos, S., Hofmann, W. K., Grogan, T. M., Krug, U., Schrage, M., Miller, T. P., Braun, J. G., Wachsman, W., Koeffler, H. P. & Said, J. W., Feb 1 2003, In : Laboratory Investigation. 83, 2, p. 271-285 15 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Follicular Lymphoma
Transcriptome
Lymphoma, Large B-Cell, Diffuse
Genes
780 Citations (Scopus)

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

Rosenwald, A., Wright, G., Leroy, K., Yu, X., Gaulard, P., Gascoyne, R. D., Chan, W. C., Zhao, T., Haioun, C., Greiner, T. C., Weisenburger, D. D., Lynch, J. C., Vose, J., Armitage, J. O., Smeland, E. B., Kvaloy, S., Holte, H., Delabie, J., Campo, E., Montserrat, E. & 18 others, Lopez-Guillermo, A., Ott, G., Muller-Hermelink, H. K., Connors, J. M., Braziel, R., Grogan, T. M., Fisher, R. I., Miller, T. P., LeBlanc, M., Chiorazzi, M., Zhao, H., Yang, L., Powell, J., Wilson, W. H., Jaffe, E. S., Simon, R., Klausner, R. D. & Staudt, L. M., Sep 15 2003, In : Journal of Experimental Medicine. 198, 6, p. 851-862 12 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
B-Cell Lymphoma
Hodgkin Disease
Gene Expression Profiling
Transcriptional Activation
4 Citations (Scopus)

Mood alterations in patients treated with chlorambucil

Hehn, S. T., Dorr, R. T. & Miller, T. P., Dec 2003, In : Clinical Lymphoma. 4, 3, p. 179-182 4 p.

Research output: Contribution to journalArticle

Chlorambucil
Psychomotor Agitation
Alkylating Agents
Lymphoma
Appointments and Schedules
683 Citations (Scopus)

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

Rosenwald, A., Wright, G., Wiestner, A., Chan, W. C., Connors, J. M., Campo, E., Gascoyne, R. D., Grogan, T. M., Muller-Hermelink, H. K., Smeland, E. B., Chiorazzi, M., Giltnane, J. M., Hurt, E. M., Zhao, H., Averett, L., Henrickson, S., Yang, L., Powell, J., Wilson, W. H., Jaffe, E. S. & 19 others, Simon, R., Klausner, R. D., Montserrat, E., Bosch, F., Greiner, T. C., Weisenburger, D. D., Sanger, W. G., Dave, B. J., Lynch, J. C., Vose, J., Armitage, J. O., Fisher, R. I., Miller, T. P., LeBlanc, M., Ott, G., Kvaloy, S., Holte, H., Delabie, J. & Staudt, L. M., Feb 2003, In : Cancer Cell. 3, 2, p. 185-197 13 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Cyclin D1
Transcriptome
Survival
Cell Cycle
2002
7 Citations (Scopus)

External beam radiation therapy in the treatment of patients with extranodal stage IA non-Hodgkin's lymphoma

Briggs, J. H., Algan, Ö., Miller, T. P. & Oleson, J. R., 2002, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 25, 1, p. 34-37 4 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Radiotherapy
Therapeutics
Disease-Free Survival
Radiation
2699 Citations (Scopus)

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Konrad Muller-Hermelink, H., Smeland, E. B., Giltnane, J. M., Hurt, E. M., Zhao, H., Averett, L., Yang, L., Wilson, W. H., Jaffe, E. S., Simon, R., Klausner, R. D., Powell, J., Duffey, P. L. & 20 others, Longo, D. L., Greiner, T. C., Weisenburger, D. D., Sanger, W. G., Dave, B. J., Lynch, J. C., Vose, J., Armitage, J. O., Montserrat, E., López-Guillermo, A., Grogan, T. M., Miller, T. P., Leblanc, M., Ott, G., Kvaloy, S., Delabie, J., Holte, H., Krajci, P., Stokke, T. & Staudt, L. M., Jun 20 2002, In : New England Journal of Medicine. 346, 25, p. 1937-1947 11 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Drug Therapy
Germinal Center
Survival
B-Lymphocytes
2001
27 Citations (Scopus)

Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: A Southwest Oncology Group Study

Gaynor, E. R., Unger, J. M., Miller, T. P., Grogan, T. M., White L.A., J., Mills, G. M., Balcerzak, S. P., Varterasian, M., LeBlanc, M. & Fisher, R. I., Feb 1 2001, In : Journal of Clinical Oncology. 19, 3, p. 750-755 6 p.

Research output: Contribution to journalArticle

Lymphoma
Drug Therapy
Non-Hodgkin's Lymphoma
Quinine
Verapamil
114 Citations (Scopus)

Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease

Press, O. W., LeBlanc, M., Lichter, A. S., Grogan, T. M., Unger, J. M., Wasserman, T. H., Gaynor, E. R., Peterson, B. A., Miller, T. P. & Fisher, R. I., Nov 15 2001, In : Journal of Clinical Oncology. 19, 22, p. 4238-4244 7 p.

Research output: Contribution to journalArticle

Lymphatic Irradiation
Vinblastine
Hodgkin Disease
Doxorubicin
Combined Modality Therapy
89 Citations (Scopus)

The Burkitt-like lymphomas: A Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features

Braziel, R. M., Arber, D. A., Slovak, M. L., Gulley, M. L., Perry, C. S., Kjeldsberg, C., Unger, J., Miller, T. P., Tubbs, R., Leith, C., Fisher, R. I. & Grogan, T. M., Jun 15 2001, In : Blood. 97, 12, p. 3713-3720 8 p.

Research output: Contribution to journalArticle

Lymphocyte Function-Associated Antigen-1
Oncology
Burkitt Lymphoma
Cell Adhesion Molecules
CD58 Antigens
2000
6 Citations (Scopus)

Combined chemotherapy plus radiotherapy for treatment of early-stage intermediate- and high-grade non-Hodgkin's lymphoma.

Briggs, J. H. & Miller, T. P., Mar 2000, In : Current Oncology Reports. 2, 2, p. 176-181 6 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Radiotherapy
Drug Therapy
Benchmarking
Combined Modality Therapy
75 Citations (Scopus)

Interferon alfa consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non- Hodgkin's lymphoma: Results of the Southwest Oncology Group randomized phase III study 8809

Fisher, R. I., Dana, B. W., LeBlanc, M., Kjeldsberg, C., Forman, J. D., Unger, J. M., Balcerzak, S. P., Gaynor, E. R., Roy, V. & Miller, T. P., May 2000, In : Journal of Clinical Oncology. 18, 10, p. 2010-2016 7 p.

Research output: Contribution to journalArticle

Interferon-alpha
Non-Hodgkin's Lymphoma
Disease-Free Survival
Drug Therapy
Interferons

Interferon does not prolong progression-free survival after ProMACE-MOPP [5] (multiple letters)

Cabanillas, F., Fisher, R. I., Leblanc, M. & Miller, T. P., Sep 15 2000, In : Journal of Clinical Oncology. 18, 18, p. 3322 1 p.

Research output: Contribution to journalArticle

Antineoplastic Combined Chemotherapy Protocols
Procarbazine
Mechlorethamine
Phase III Clinical Trials
Vincristine
55 Citations (Scopus)

Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma

Stopeck, A. T., Gessner, A., Miller, T. P., Hersh, E. M., Johnson, C. S., Cui, H., Frutiger, Y. & Grogan, T. M., 2000, In : Clinical Cancer Research. 6, 10, p. 3904-3909 6 p.

Research output: Contribution to journalArticle

Tumor-Infiltrating Lymphocytes
Lymphoma, Large B-Cell, Diffuse
T-Lymphocytes
Neoplasms
HLA-DR Antigens
18 Citations (Scopus)

Phase II evaluation of interleukin-4 in patients with non-Hodgkin's lymphoma: A Southwest oncology group trial

Taylor, C. W., LeBlanc, M., Fisher, R. I., Moore, D. F., Roach, R. W., Elias, L. & Miller, T. P., 2000, In : Anti-Cancer Drugs. 11, 9, p. 695-700 6 p.

Research output: Contribution to journalArticle

Interleukin-4
Non-Hodgkin's Lymphoma
Drug Therapy
Chills
Lethargy
1999
1 Citation (Scopus)

Phase II trial of menogaril in non-Hodgkin's lymphomas: A southwest oncology group trial

Moore, D. F., Brown, T. D., LeBlanc, M., Dahlberg, S., Miller, T. P., McClure, S. & Fisher, R. I., 1999, In : Investigational New Drugs. 17, 2, p. 169-172 4 p.

Research output: Contribution to journalArticle

Menogaril
Non-Hodgkin's Lymphoma
Histology
Confidence Intervals
Drug Therapy
1998
24 Citations (Scopus)

A phase I/II trial of paclitaxel for non-Hodgkin's lymphoma followed by paclitaxel plus quinine in drug-resistant disease

Miller, T. P., Chase, E. M., Dorr, R. T., Dalton, W. S., Lam, K. S. & Salmon, S. E., 1998, In : Anti-Cancer Drugs. 9, 2, p. 135-140 6 p.

Research output: Contribution to journalArticle

Quinine
Paclitaxel
Non-Hodgkin's Lymphoma
Pharmaceutical Preparations
Pharmacokinetics
789 Citations (Scopus)

Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma

Miller, T. P., Dahlberg, S., Cassady, J. R., Adelstein, D. J., Perry, C. S., Grogan, T. M., LeBlanc, M., Carlin, S., Chase, E. & Fisher, R. I., Jul 2 1998, In : New England Journal of Medicine. 339, 1, p. 21-26 6 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Radiotherapy
Drug Therapy
Disease-Free Survival
Poisons
6 Citations (Scopus)

Management of intermediate-grade lymphomas

Miller, T. P., 1998, In : Oncology (Williston Park, N.Y.). 12, 10 SUPPL. 8, p. 35-39 5 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Cyclophosphamide
Vincristine
Doxorubicin
Survival
12 Citations (Scopus)

New REAL clinical entities

Fisher, R. I., Miller, T. P. & Grogan, T. M., 1998, In : Cancer Journal from Scientific American. 4, SUPPL. 2

Research output: Contribution to journalArticle

Lymphoma
Non-Hodgkin's Lymphoma
B-Lymphocytes
Mantle-Cell Lymphoma
Null Lymphocytes
1 Citation (Scopus)

Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma [1] (multiple letters)

Wirth, A., Prince, H. M., Wolf, M., Machida, U., Kami, M., Hirai, H., Mounier, N., Gisselbrecht, C., Lepage, E., Kosmas, C., Malamos, N. A., Antonopoulos, M. J., Decaudin, D., Miller, T. P., LeBlanc, M. & Fisher, R. I., Nov 12 1998, In : New England Journal of Medicine. 339, 20, p. 1475-1477 3 p.

Research output: Contribution to journalArticle

Antineoplastic Combined Chemotherapy Protocols
Combined Modality Therapy
Patient Dropouts
Age Factors
Vincristine
1997
11 Citations (Scopus)

A southwest oncology group perspective on the revised European-American lymphoma classification

Grogan, T. M., Miller, T. P., Fisher, R. I. & Graff, J. C., 1997, In : Hematology/Oncology Clinics of North America. 11, 5, p. 819-846 28 p.

Research output: Contribution to journalArticle

Lymphoma
Terminology
Names
Neoplasms
42 Citations (Scopus)

Follicular lymphomas: Do histologic subtypes predict outcome?

Miller, T. P., LeBlanc, M., Grogan, T. M., Fisher, R. I. & Graff, J. C., 1997, In : Hematology/Oncology Clinics of North America. 11, 5, p. 893-900 8 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Lymphoma
Therapeutics
1996
6 Citations (Scopus)

The phenomenon of multidrug resistance in non-Hodgkin's lymphoma.

Miller, T. P., Chase, E. M., Dalton, W. S. & Grogan, T. M., 1996, In : Cancer Treatment and Research. 85, p. 107-117 11 p.

Research output: Contribution to journalArticle

Multiple Drug Resistance
P-Glycoprotein
Non-Hodgkin's Lymphoma
1995
304 Citations (Scopus)

A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): A Southwest oncology group study

Fisher, R. I., Dahlberg, S., Nathwani, B. N., Banks, P. M., Miller, T. P. & Grogan, T. M., Feb 15 1995, In : Blood. 85, 4, p. 1075-1082 8 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Marginal Zone B-Cell Lymphoma
Oncology
Lymphoma
B-Lymphocytes
1994
64 Citations (Scopus)

A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: Results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study

Fisher, R. I., Gaynor, E. R., Dahlberg, S., Oken, M. M., Grogan, T. M., Mize, E. M., Glick, J. H., Coltman, C. A. & Miller, T. P., 1994, In : Annals of Oncology. 5, SUPPL. 2, p. 91-95 5 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Lymphoma
Survival
Treatment Failure
Combination Drug Therapy
1 Citation (Scopus)

A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma

Grever, M. R., Benedetti, J., Balcerzak, S. P., Taylor, S. A., Miller, T. P. & Dakhil, S. R., Sep 1994, In : Investigational New Drugs. 12, 3, p. 259-261 3 p.

Research output: Contribution to journalArticle

Antineoplastic Antimetabolites
Vidarabine Phosphate
Hematologic Diseases
Sleep Stages
Sarcoma
146 Citations (Scopus)

Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease: A Southwest Oncology Group randomized study

Fabian, C. J., Mansfield, C. M., Dahlberg, S., Jones, S. E., Miller, T. P., Van Slyck, E., Grozea, P. N., Morrison, F. S., Coltman, C. A. & Fisher, R. I., Jun 1 1994, In : Annals of Internal Medicine. 120, 11, p. 903-912 10 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Radiation
Drug Therapy
Sclerosis
Survival
5 Citations (Scopus)

Phase II evaluation of mitoxantrone plus cis-platinum in patients with advanced breast cancer - A Southwest Oncology Group study

Atiba, J. O., Green, S. J., Hynes, H. E., Osborne, C. K., Miller, T. P. & Davidner, M., Jun 1994, In : Investigational New Drugs. 12, 2, p. 129-132 4 p.

Research output: Contribution to journalArticle

Mitoxantrone
Cisplatin
Breast Neoplasms
Agranulocytosis
Leukopenia
218 Citations (Scopus)

Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: A prospective Southwest Oncology Group trial

Miller, T. P., Grogan, T. M., Dahlberg, S., Perry, C. S., Braziel, R. M., Banks, P. M., Foucar, K., Kjeldsberg, C. R., Levy, N., Nathwani, B. N., Schnitzer, B., Tubbs, R. R., Gaynor, E. R. & Fisher, R. I., Mar 15 1994, In : Blood. 83, 6, p. 1460-1466 7 p.

Research output: Contribution to journalArticle

Oncology
Non-Hodgkin's Lymphoma
Monoclonal Antibodies
Antigens
Survival
2 Citations (Scopus)

The presence of bcl-l and bci-2 gene rearrangements in diffuse small cleaved-cell lymphoma

Leith, C. P., Willman, C. L., Perry, C. S., Miller, T. P. & Grogan, T. M., 1994, In : Diagnostic Molecular Pathology. 3, 3, p. 178-183 6 p.

Research output: Contribution to journalArticle

Gene Rearrangement
Non-Hodgkin's Lymphoma
Follicular Lymphoma
Survival
Genotype
1993
1873 Citations (Scopus)

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

Fisher, R. I., Gaynor, E. R., Dahlberg, S., Oken, M. M., Grogan, H. M., Mize, E. M., Glick, J. H., Coltman, C. A. & Miller, T. P., Apr 8 1993, In : New England Journal of Medicine. 328, 14, p. 1002-1006 5 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Drug Therapy
Vincristine
Doxorubicin
Cyclophosphamide
45 Citations (Scopus)

Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: Relationship to HLA expression and host immunocompetence

List, A. F., Perry, C. S., Miller, T. P. & Grogan, T. M., Mar 1993, In : Leukemia. 7, 3, p. 398-403 6 p.

Research output: Contribution to journalArticle

Tumor-Infiltrating Lymphocytes
Immunocompetence
Lymphoma
T-Lymphocytes
B-Cell Lymphoma
11 Citations (Scopus)

Immunobiologic correlates of prognosis in lymphoma

Grogan, T. M. & Miller, T. P., 1993, In : Seminars in Oncology. 20, SUPPL. 5, p. 58-74 17 p.

Research output: Contribution to journalArticle

Neoplasm DNA
Neoplastic Cell Transformation
Tumor-Infiltrating Lymphocytes
Immunophenotyping
Lymphocyte Subsets
184 Citations (Scopus)

Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy

Dana, B. W., Dahlberg, S., Nathwani, B. N., Chase, E., Coltman, C., Miller, T. P. & Fisher, R. I., 1993, In : Journal of Clinical Oncology. 11, 4, p. 644-651 8 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Doxorubicin
Lymphoma
Drug Therapy
Survival
40 Citations (Scopus)

NCAM (CD56)-positive malignant lymphoma

Kern, W. F., Perry, C. S., Miller, T. P. & Grogan, T. M., 1993, In : Leukemia and Lymphoma. 12, 1-2, p. 1-10 10 p.

Research output: Contribution to journalArticle

Neural Cell Adhesion Molecules
Lymphoma
Cell Adhesion Molecules
Cell Adhesion
Neoplasms
34 Citations (Scopus)

Radiation therapy salvage of Hodgkin's disease following chemotherapy failure

Leigh, B. R., Fox, K. A., Mack, C. F., Baier, M., Miller, T. P. & Cassady, J. R., Nov 15 1993, In : International Journal of Radiation Oncology Biology Physics. 27, 4, p. 855-862 8 p.

Research output: Contribution to journalArticle

chemotherapy
Hodgkin Disease
radiation therapy
Radiotherapy
Drug Therapy
4 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
Patient Selection
Therapeutics
1992
15 Citations (Scopus)

Diffuse small cleaved-cell lymphoma: A heterogeneous disease with distinct immunobiologic subsets

Leith, C. P., Perry, C. S., Grogan, T. M., Gonzales, G., Rangel, C. S., Rybski, J. A., Matzner, M. & Miller, T. P., 1992, In : Journal of Clinical Oncology. 10, 8, p. 1259-1265 7 p.

Research output: Contribution to journalArticle

L-Lactate Dehydrogenase
Non-Hodgkin's Lymphoma
Cell Lineage
Survival
B-Lymphocytes
215 Citations (Scopus)

Neural cell adhesion molecule-positive peripheral T-cell lymphoma: A rare variant with a propensity for unusual sites of involvement

Kern, W. F., Perry, C. S., Hanneman, E. H., Miller, T. P., Matzner, M. & Grogan, T. M., May 1 1992, In : Blood. 79, 9, p. 2432-2437 6 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Neural Cell Adhesion Molecules
T-cells
Nasopharynx
Polymerase chain reaction
1991

A clinical phase II study of ProMACE-CytaBOM [1]

Dahlberg, S., Miller, T. P. & Fisher, R. I., 1991, In : Journal of Clinical Oncology. 9, 5, p. 888 1 p.

Research output: Contribution to journalArticle

Antineoplastic Combined Chemotherapy Protocols
Drug Evaluation
Cytarabine
Bleomycin
Vincristine

Activity of esorubicin in recurrent malignant lymphoma: A southwest oncology group study

Miller, T. P., Dahlberg, S., Salmon, S. E., Williamson, S. K., Belt, R. J., Dana, B. W. & Fisher, R. I., 1991, In : Journal of Clinical Oncology. 9, 7, p. 1204-1209 6 p.

Research output: Contribution to journalArticle

Lymphoma
Non-Hodgkin's Lymphoma
Hodgkin Disease
esorubicin
Recurrence
36 Citations (Scopus)

Combination chemotherapy of intermediate-grade and high-grade non-Hodgkin's lymphoma with MACOP-B: A Southwest Oncology Group study

Weick, J. K., Dahlberg, S., Fisher, R. I., Dana, B., Miller, T. P., Balcerzak, S. P. & Pierce, H. I., 1991, In : Journal of Clinical Oncology. 9, 5, p. 748-753 6 p.

Research output: Contribution to journalArticle

Combination Drug Therapy
Non-Hodgkin's Lymphoma
Histology
Mucositis
Leucovorin
27 Citations (Scopus)

Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas

Fisher, R. I., Longo, D. L., DeVita, V. T., Hubbard, S. M., Miller, T. P. & Young, R. C., 1991, In : Annals of Oncology. 2, SUPPL. 1, p. 33-35 3 p.

Research output: Contribution to journalArticle

Etoposide
Prednisone
Methotrexate
Non-Hodgkin's Lymphoma
Doxorubicin
44 Citations (Scopus)

Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease

Silver, R. T., Case, D. C., Wheeler, R. H., Miller, T. P., Stein, R. S., Stuart, J. J., Peterson, B. A., Rivkin, S. E., Golomb, H. M., Costanzi, J. J., Erslev, A. J., Reisman, A. & Dugan, M., 1991, In : Journal of Clinical Oncology. 9, 5, p. 754-761 8 p.

Research output: Contribution to journalArticle

Mitoxantrone
Hodgkin Disease
Non-Hodgkin's Lymphoma
Multicenter Studies
Clinical Trials